Abstract
Purpose
Two case–control studies reported a 50 % decreased breast cancer risk among women who experienced menopausal vasomotor symptoms (VMS), but one cohort study found no association. VMS may be triggered by declining estrogen levels during menopause, whereas elevated estrogen levels have been associated with increased breast cancer risk. VMS may thus be indicative of lower susceptibility to breast cancer.
Methods
We evaluated this relationship in the longitudinal Study of Women’s Health Across the Nation (SWAN), using discrete survival analysis of approximately annual data on VMS and self-reported breast cancer occurrences for up to 13 years of follow-up in 3,098 women who were pre- or early perimenopausal at enrollment.
Results
Over an average 11.4 years of follow-up, 129 incident breast cancer cases were self-reported, and approximately 50 % of participants experienced VMS. Symptomatic women had a reduced risk of breast cancer compared to non-symptomatic women (adjusted HR 0.63, 95 % CI 0.39, 1.00). The association was stronger in the subgroup of women who fully transitioned to postmenopause during follow-up (n = 67 cases, adjusted HR 0.45, 95 % CI 0.26, 0.77).
Conclusion
VMS appeared to be a marker of reduced breast cancer risk. Future research is needed to understand the biology underlying this relationship.
Similar content being viewed by others
References
Fei C, DeRoo LA, Sandler DP et al (2013) Menopausal symptoms and the risk of young-onset breast cancer. Eur J Cancer 49:798–804
Huang Y, Malone KE, Cushing-Haugen KL et al (2011) Relationship between menopausal symptoms and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 20:379–388
Johanneke van den Berg M, Mishra GD, van der Schouw YT et al (2014) Vasomotor menopausal symptoms are not associated with incidence of breast cancer in a population-based cohort of mid-aged women. Eur J Cancer 50:824–830
Crawford S, Avis N, Kelsey J et al (2004) Is annual measurement of hot flashes sufficiently frequent in perimenopause? [abstract]. Menopause 11:682
Collaborative Group on Hormonal Factors in Breast Cancer (2012) Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13:1141–1151
Hankinson SE (2005) Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 24:3–15
Gompel A, Santen RJ (2012) Hormone therapy and breast cancer risk 10 years after the WHI. Climacteric 15:241–249
Al-Azzawi F, Palacios S (2009) Hormonal changes during menopause. Maturitas 63:135–137
Alexander C, Cochran CJ, Gallicchio L et al (2010) Serum leptin levels, hormone levels, and hot flashes in midlife women. Fertil Steril 94:1037–1043
Freedman RR (2005) Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 23:117–125
Maclennan AH (2009) Evidence-based review of therapies at the menopause. Int J Evid Based Healthc 7:112–123
Sowers M, Crawford S, Sternfeld B et al (2000) SWAN: A multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo R, Kelsey J, Marcus R, Lobo AR (eds) Menopause: biology and pathology. Academic Press, New York, pp 175–188
Crandall CJ, Zheng Y, Crawford SL et al (2009) Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause 16:239–246
Thurston RC, El Khoudary SR, Sutton-Tyrrell K et al (2012) Vasomotor symptoms and insulin resistance in the study of women’s health across the nation. J Clin Endocrinol Metab 97:3487–3494
Thurston RC, Sutton-Tyrrell K, Everson-Rose SA et al (2008) Hot flashes and subclinical cardiovascular disease: findings from the Study of Women’s Health Across the Nation Heart Study. Circulation 118:1234–1240
Gold EB, Colvin A, Avis N et al (2006) Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nation. Am J Public Health 96:1226–1235
Butler LM, Gold EB, Conroy SM et al (2010) Active, but not passive cigarette smoking was inversely associated with mammographic density. Cancer Causes Control 21:301–311
Conroy SM, Butler LM, Harvey D et al (2010) Physical activity and change in mammographic density: the Study of Women’s Health Across the Nation. Am J Epidemiol 171:960–968
Block G, Hartman AM, Dresser CM et al (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124:453–469
Allison PD (2010) Survival analysis using SAS: A practical guide, 2nd edn. SAS Institute, Cary
Avis NE, Crawford SL, McKinlay SM (1997) Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 3:103–120
Freeman EW, Sammel MD, Lin H et al (2005) The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 12:258–266
Avis NE, Stellato R, Crawford S et al (2001) Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 52:345–356
Grisso JA, Freeman EW, Maurin E et al (1999) Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med 14:98–103
Brown DE, Sievert LL, Morrison LA et al (2009) Do Japanese American women really have fewer hot flashes than European Americans? The Hilo Women’s Health Study. Menopause 16:870–876
Key T, Appleby P, Barnes I et al (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616
Freedman RR, Blacker CM (2002) Estrogen raises the sweating threshold in postmenopausal women with hot flashes. Fertil Steril 77:487–490
Berendsen HH (2000) The role of serotonin in hot flushes. Maturitas 36:155–164
Bergmann MM, Calle EE, Mervis CA et al (1998) Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 147:556–562
Stavrou E, Vajdic CM, Loxton D et al (2011) The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women. Cancer Epidemiol 35:e75–e80
Financial support
The Study of Women’s Health Across the Nation (SWAN) has grant support from the National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR), and the NIH Office of Research on Women’s Health (ORWH) (Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH, or the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Hart, V., Sturgeon, S.R., Reich, N. et al. Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation. Cancer Causes Control 27, 1333–1340 (2016). https://doi.org/10.1007/s10552-016-0811-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-016-0811-9